• News
  • BioTech

Lpath awarded NIH grant for traumatic brain injury treatment

San Diego-based Lpath Inc. (Nasdaq: LPTN) received official notification from the National Institutes of Neurological Diseases and Stroke (NINDS) that it has been awarded a $1.7 million, 2.5-year grant to develop its antibody therapeutic, Lpathomab.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!